ASBP
Income statement / Annual
Last year (2025), Aspire Biopharma Holdings Inc.'s total revenue was $6.20 K,
and the percentage change from the previous year is not available.
In 2025, Aspire Biopharma Holdings Inc.'s net income was -$24.48 M.
See Aspire Biopharma Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
| Operating Revenue |
$6.20 K |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$6.32 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
-$116.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
-0.02
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$923.91 K
|
$144.36 K
|
$72.05 K
|
$175.32 K
|
$0.00
|
| General & Administrative Expenses |
$17.64 M
|
$3.09 M
|
$1.34 M
|
$976.35 K
|
$27.79 K
|
| Selling & Marketing Expenses |
$789.83 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.43 M
|
$3.09 M
|
$1.34 M
|
$976.35 K
|
$27.79 K
|
| Other Expenses |
$0.00
|
-$144.36 K
|
-$72.05 K
|
-$175.32 K
|
-$2.32 K
|
| Operating Expenses |
$19.35 M
|
$3.09 M
|
$1.34 M
|
$976.35 K
|
$25.48 K
|
| Cost And Expenses |
$19.36 M
|
$3.09 M
|
$1.34 M
|
$976.35 K
|
$25.48 K
|
| Interest Income |
$0.00
|
$548.68 K
|
$5.81 M
|
$4.32 M
|
$0.00
|
| Interest Expense |
$8.53 M
|
-$892.00 K
|
$8.97 K
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$0.00
|
$1.34 M
|
$0.00
|
$27.79 K
|
| EBITDA |
-$19.35 M |
-$11.65 M |
$5.80 M |
$3.34 M |
-$25.48 K |
| EBITDA Ratio |
-3120.17
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
-3120.17
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$5.13 M
|
-$9.45 M
|
$5.80 M
|
$4.32 M
|
$5.00
|
| Income Before Tax |
-$24.48 M
|
-$12.54 M
|
$4.46 M
|
$3.34 M
|
-$25.48 K
|
| Income Before Tax Ratio |
-3947.25
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$1.01 K
|
$0.00
|
$626.00
|
$0.00
|
| Net Income |
-$24.48 M
|
-$12.54 M
|
$4.46 M
|
$3.34 M
|
-$25.48 K
|
| Net Income Ratio |
-3947.25
|
0
|
0
|
0
|
0
|
| EPS |
-16.38 |
-18.17 |
9.31 |
3.72 |
-0.0373 |
| EPS Diluted |
-16.38 |
-18.17 |
9.31 |
3.72 |
-0.0373 |
| Weighted Average Shares Out |
$1.49 M
|
$689.91 K
|
$479.48 K
|
$898.44 K
|
$682.81 K
|
| Weighted Average Shares Out Diluted |
$1.49 M
|
$689.91 K
|
$479.48 K
|
$898.44 K
|
$682.81 K
|
| Link |
|
|
|
|
|
